Programmed cell death-ligand 1 expression in stromal immune cells is a marker of breast cancer outcome

Purpose: The programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) axis plays an important role in antitumor immune responses. However, there is considerable inconsistency regarding the prognostic value of PD-L1 expression status in breast cancer. We sought to evaluate the differenti...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Mineui, Kim, Jeong Won, Kim, Min kyoon, Chung, Bong wha, Ahn, Soo kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646181/
https://www.ncbi.nlm.nih.gov/pubmed/33193888
http://dx.doi.org/10.7150/jca.50441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646181/
https://www.ncbi.nlm.nih.gov/pubmed/33193888
http://dx.doi.org/10.7150/jca.50441

Ejemplares similares